Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2026 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2026 Earnings Call Transcript April 30, 2026

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.51, expectations were $0.895.

Operator: Hello, and thank you for standing by. My name is Ian, and I will be your conference operator today. At this time, I would like to welcome everyone to the Alnylam Pharmaceuticals Q1 Earnings Conference Call. [Operator Instructions] I would now like to turn this call over to the company....